FDA Inspection 1037726 — Heartland Pathology Diagnostics, LLC
The FDA completed an inspection of Heartland Pathology Diagnostics, LLC on December 14, 2017 in Wichita, KS. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- December 14, 2017
- Fiscal Year
- 2018
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Wichita, KS (United States)